MX9606137A - Compositions and methods for the treatment of tumors. - Google Patents

Compositions and methods for the treatment of tumors.

Info

Publication number
MX9606137A
MX9606137A MX9606137A MX9606137A MX9606137A MX 9606137 A MX9606137 A MX 9606137A MX 9606137 A MX9606137 A MX 9606137A MX 9606137 A MX9606137 A MX 9606137A MX 9606137 A MX9606137 A MX 9606137A
Authority
MX
Mexico
Prior art keywords
tumors
treatment
compositions
methods
cytokine
Prior art date
Application number
MX9606137A
Other languages
Spanish (es)
Other versions
MXPA96006137A (en
Inventor
Gordon A Vehar
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US1995/007305 external-priority patent/WO1995034319A1/en
Publication of MXPA96006137A publication Critical patent/MXPA96006137A/en
Publication of MX9606137A publication Critical patent/MX9606137A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention concerns a method for inhibiting the growth and/or causing regression of tumors by administering a therapeutically effective dose of a procoagulant and a cytokine, preferably TNF-'beta', TNF-'alpha' and/or IL-1. In a specific aspect, the invention concerns a method for tumor treatment by the administration of a therapeutically effective amount of a thrombomodulin inhibitor and a cytokine. The invention also concerns thrombomodulin inhibitors and pharmaceutical compositions used in the course of these treatments.
MX9606137A 1995-06-08 1995-06-08 Compositions and methods for the treatment of tumors. MX9606137A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US260850 1994-06-16
US260,850 1994-06-16
PCT/US1995/007305 WO1995034319A1 (en) 1994-06-16 1995-06-08 Compositions and methods for the treatment of tumors

Publications (2)

Publication Number Publication Date
MXPA96006137A MXPA96006137A (en) 1998-01-01
MX9606137A true MX9606137A (en) 1998-01-31

Family

ID=39165235

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9606137A MX9606137A (en) 1995-06-08 1995-06-08 Compositions and methods for the treatment of tumors.

Country Status (1)

Country Link
MX (1) MX9606137A (en)

Similar Documents

Publication Publication Date Title
MXPA03003960A (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders.
UA41906C2 (en) Method for treating neurological disorders due to trauma
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
SE9301951D0 (en) METHODS FOR ADMINISTRATION OF TAXOL
MX9604145A (en) Methods and compositions useful for inhibition of angiogenesis.
PT804252E (en) METALLIC CHELTER AGENTS THAT CONTAINS DIAMOND MONOAMINES AND THIOIS
CA2102429A1 (en) Bone growth factors and inhibitors of bone resorption for promoting bone formation
UA42747C2 (en) Peptide derivatives, pharmaceutical composition and method for stimulating growth hormone releasing
UA26213C2 (en) MEANS FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS AND PHARMACEUTICAL COMPOSITION AND THEIR BASES
GEP20063773B (en) Steroid Sulphatase Inhibitors
AU7031500A (en) Therapeutic quinazoline compounds
ATE170077T1 (en) METHOD FOR TREATING CANCER BY COMBINATION THERAPY WITH 2'-HALOMETHYLIDE DERIVATIVES AND AN S-OR M-PHASE-SPECIFIC ANTINEOPLASTIC ACTIVE INGREDIENT
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
PL323617A1 (en) Pharmaceutical preparation for treating oestrogen-dependent carcinomas
ES2160643T3 (en) COMPOSITIONS CONTAINING G-CSF AND PROTEIN OF UNION TO TNF.
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
SE9603725D0 (en) New teatment
RU94040886A (en) Use of melatonine derivatives for sleep disturbance treatment, pharmaceutical composition
BR0110396A (en) Methods to prevent and treat chemotherapy or radiotherapy-induced alopecia
RU94041028A (en) Application of melatonin derivatives for treating desynchronization disorders, pharmaceutical composition
GB2331926A (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
GR3023645T3 (en) Treatment of liver cancer
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat